Holen Sie sich die Stockscreener-App
96.56
0.26%
0.25
Handel nachbörslich:
96.57
0.010
+0.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’ - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Trading Down 0.6%What's Next? - MarketBeat
Stocks Flash: Biggest Recent Disappointment (Merck & Co Inc., MRK) and Biggest Bright Spot (Dell Technologies Inc, DELL) - Elliott Wave International
Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now? - Insider Monkey
Braun Stacey Associates Inc. Lowers Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
AMG National Trust Bank Sells 5,505 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Aljian Capital Management LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by TrinityPoint Wealth LLC - MarketBeat
Swiss National Bank Has $853.74 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Thrivent Financial for Lutherans - MarketBeat
Concord Asset Management LLC VA Has $5.08 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Mutual of America Capital Management LLC Decreases Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Mizuho Securities USA LLC Sells 53,617 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Holdings Decreased by Natixis Advisors LLC - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Lowers Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Kentucky Retirement Systems Has $20.05 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Intellectus Partners LLC Takes $730,000 Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Shares Down 2.4%Here's What Happened - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Archer Investment Corp - MarketBeat
Empowered Funds LLC Buys 147,267 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Sheaff Brock Investment Advisors LLC Has $13.94 Million Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Signature Estate & Investment Advisors LLC Acquires 48,807 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) is Cornercap Investment Counsel Inc.'s 4th Largest Position - MarketBeat
Merck: CHMP gives green light for Keytruda in pleural mesothelioma - Marketscreener.com
Wolfe Research Initiates Coverage on Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by CIBC Asset Management Inc - MarketBeat
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co. Jumps Into PD-1/VEGF Bispecific Race With LaNova Deal - Scrip
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 0.3%Time to Sell? - MarketBeat
Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd - Marketscreener.com
ING Groep NV Sells 281,509 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Lifeworks Advisors LLC Raises Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Ferguson Wellman Capital Management Inc. Grows Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: acquires exclusive license from LaNova Medicines - Marketscreener.com
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Curi RMB Capital LLC - MarketBeat
Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal - BioSpace
Merck: Keytruda’s Sales Projections Outweigh Competitive And Patent Risks (NYSE:MRK) - Seeking Alpha
Merck signs up to $3.3 billion cancer drug deal with China-based LaNova - Reuters
KBC Group NV Sells 884,248 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck stock on watch after cancer drug deal (NYSE:MRK) - Seeking Alpha
5 Dow Jones Giants With High Upside Potential and Rock-Solid Financial Health - Investing.com
Merck to Participate in the Jefferies London Healthcare Conference - Business Wire
Merck (MRK) Enters into Exclusive Global License for LM-299 - StreetInsider.com
Merck Inks $3.3B Bispecific Antibody Deal with LaNova Medicines | MRK Stock News - StockTitan
Merck Snags Chinese Cancer Drug For Up to $3.3 Billion - BNN Bloomberg
GSA Capital Partners LLP Invests $1.44 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.4%Should You Sell? - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Main Street Financial Solutions LLC - MarketBeat
Oppenheimer & Co. Inc. Buys 6,503 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Oppenheimer Asset Management Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Boosted by Pinnacle Financial Partners Inc - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Haverford Trust Co - MarketBeat
Buck Wealth Strategies LLC Sells 7,081 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
WCM Investment Management LLC Acquires 10,482 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 1%Time to Sell? - MarketBeat
Merck & Co. Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
AZ And Merck Notch Another Win For Koselugo In Adults With NF1 - Citeline News & Insights
Victory Capital Management Inc. Has $337.66 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Aptus Capital Advisors LLC Acquires 43,852 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: promising results from Koselugo study - Marketscreener.com
Merck: new data on HPV vaccine - Marketscreener.com
Alexion, AstraZeneca Rare Disease and Merck Announces Positive Topline Results from the Phase 3 Komet Trial - Marketscreener.com
Prime Capital Investment Advisors LLC Boosts Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Ashton Thomas Private Wealth LLC Reduces Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Boosts Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Downgraded to "Hold" Rating by Daiwa America - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Cuts Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Entropy Technologies LP Grows Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Apollon Wealth Management LLC Sells 5,538 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
With 79% ownership, Merck & Co., Inc. (NYSE:MRK) boasts of strong institutional backing - Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) Shares Down 1.4%Here's Why - MarketBeat
0.02%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):